These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23599014)

  • 1. Synthesis, biological evaluation, and pharmacokinetic study of novel liguzinediol prodrugs.
    Liu Z; Li W; Wen HM; Bian HM; Zhang J; Chen L; Chen L; Yang KD
    Molecules; 2013 Apr; 18(4):4561-72. PubMed ID: 23599014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of liguzinediol mono- and dual ester prodrugs as promising inotropic agents.
    Zhang J; Li W; Wen HM; Zhu HH; Wang TL; Cheng D; Yang KD; Chen YQ
    Molecules; 2014 Nov; 19(11):18057-72. PubMed ID: 25379643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel compound liguzinediol exerts positive inotropic effects in isolated rat heart via sarcoplasmic reticulum Ca2+ ATPase-dependent mechanism.
    Chen L; Xu Y; Li W; Wu H; Luo Z; Li X; Huang F; Young C; Liu Z; Zhou S
    Life Sci; 2012 Oct; 91(11-12):402-408. PubMed ID: 22906633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffold evaluation of liguzinediol analogs as novel cardiotonic agents.
    Liu Z; Li W; Qin K; Wen K; Zhu CJ; Li NG; Bian HM; Wen HM; Chen L
    Pharmazie; 2013 Dec; 68(12):926-32. PubMed ID: 24400437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
    Bandgar BP; Sarangdhar RJ; Ahamed FA; Viswakarma S
    J Med Chem; 2011 Mar; 54(5):1202-10. PubMed ID: 21250699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liguzinediol Enhances the Inotropic Effect of Rat Hearts via Inhibition of Protein Phosphatase (PP1 and PP2A) Activities.
    Li S; Huang H; Zhang M; Wang W; Xue S; Gao Y; Xie M; Chen K; Liu F; Chen L
    J Cardiovasc Pharmacol; 2017 Apr; 69(4):236-244. PubMed ID: 28134629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and positive inotropic activity evaluation of liguzinediol metabolites.
    Zhu HH; Chen YQ; Cheng D; Li W; Wang TL; Wen HM; Chen L; Liu J
    Bioorg Med Chem Lett; 2016 Feb; 26(3):882-884. PubMed ID: 26725025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers.
    Gupta D; Gupta SV; Lee KD; Amidon GL
    Mol Pharm; 2009; 6(5):1604-11. PubMed ID: 19566080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamate ester prodrugs of dopaminergic compounds: synthesis, stability, and bioconversion.
    Hansen KT; Faarup P; Bundgaard H
    J Pharm Sci; 1991 Aug; 80(8):793-8. PubMed ID: 1686464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfotransferase-catalyzed biotransformation of liguzinediol and comparison of its metabolism in different species using UFLC-QTOF-MS.
    Shen F; Wen HM; Shan CX; Kang A; Dong B; Chai C; Zhang JY; Zhang Q; Li W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():1-7. PubMed ID: 29738966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved design of water-soluble propofol prodrugs characterized by rapid onset of action.
    Lang BC; Yang J; Wang Y; Luo Y; Kang Y; Liu J; Zhang WS
    Anesth Analg; 2014 Apr; 118(4):745-54. PubMed ID: 24651228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrugs of 2',3'-didehydro-3'-deoxythymidine.
    Hasegawa T; Seki T; Juni K; Saneyoshi M; Kawaguchi T
    J Pharm Sci; 1993 Dec; 82(12):1232-6. PubMed ID: 8308702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of orally active prodrugs of indomethacin.
    Bandgar BP; Sarangdhar RJ; Viswakarma S; Ahamed FA
    J Med Chem; 2011 Mar; 54(5):1191-201. PubMed ID: 21284386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water soluble cyclosporine monomethoxy poly(ethyleneglycol) conjugates as potential prodrugs.
    Cho H; Chung Y
    Arch Pharm Res; 2004 Jun; 27(6):662-9. PubMed ID: 15283470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of N-acylsulfonamide and N-acylsulfonylurea prodrugs of a prostacyclin receptor agonist.
    Nakamura A; Yamada T; Asaki T
    Bioorg Med Chem; 2007 Dec; 15(24):7720-5. PubMed ID: 17881233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
    Yang JZ; Chen W; Borchardt RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
    Krise JP; Charman WN; Charman SA; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation.
    Tammara VK; Narurkar MM; Crider AM; Khan MA
    J Pharm Sci; 1994 May; 83(5):644-8. PubMed ID: 8071813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.